SGTI Financials 07/16/2014 06:05:03 Shengtai Phar

SGTI Financials 07/16/2014 06:05:03
Shengtai Pharmaceutical, Inc.
Period Ending Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 179,029 171,718 115,954
Cost of Revenue 161,705 148,594 98,276
Gross Profit 17,324 23,124 17,678
Operating Expenses
Research and Development - - -
Sales, General and Admin. 11,825 9,805 10,282
Non-Recurring Items - - -
Other - - -
Operating Income 5,499 13,319 7,396
Income From Continuing Operations
Add'l Income/Expense Items 767 36 334
Earnings Before Interest and Tax 7,187 14,227 8,458
Interest Expense 6,116 3,729 3,660
Earnings Before Tax 1,072 10,498 4,798
Income Tax (1) 2,847 1,599
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary 922 873 728
Net Income Cont. Operations 1,994 8,524 3,927
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income 1,073 7,651 3,199
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders 1,073 7,651 3,199